Genomtec S.A.
GMT.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 104,398 | PLN 100,766 | PLN 117,153 | PLN 104,731 |
| - Cash | PLN 7,402 | PLN 9,876 | PLN 13,839 | PLN 6,697 |
| + Debt | PLN 2,130 | PLN 1,938 | PLN 2,576 | PLN 2,736 |
| Enterprise Value | PLN 99,126 | PLN 92,828 | PLN 105,890 | PLN 100,770 |
| Revenue | PLN 4 | PLN 6 | PLN 5 | PLN 0 |
| % Growth | -33.3% | 20% | – | – |
| Gross Profit | -PLN 5,730 | -PLN 3,065 | -PLN 1,092 | PLN 480 |
| % Margin | -143,250% | -51,083.3% | -21,840% | – |
| EBITDA | -PLN 1,851 | -PLN 2,437 | -PLN 2,515 | -PLN 1,287 |
| % Margin | -46,275% | -40,616.7% | -50,300% | – |
| Net Income | -PLN 2,572 | -PLN 3,350 | -PLN 3,205 | -PLN 1,882 |
| % Margin | -64,300% | -55,833.3% | -64,100% | – |
| EPS Diluted | -0.17 | -0.23 | -0.22 | -0.14 |
| % Growth | 26.1% | -4.5% | -57.1% | – |
| Operating Cash Flow | -PLN 2,196 | -PLN 3,172 | -PLN 3,357 | PLN 925 |
| Capital Expenditures | -PLN 21 | -PLN 51 | PLN 0 | -PLN 45 |
| Free Cash Flow | -PLN 2,217 | -PLN 3,223 | -PLN 3,357 | PLN 880 |